SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Willén Magnus) "

Sökning: WFRF:(Willén Magnus)

  • Resultat 1-10 av 12
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Danielsson, Åke, et al. (författare)
  • A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis
  • 1987
  • Ingår i: Scandinavian Journal of Gastroenterology. - : Informa UK Limited. - 0036-5521 .- 1502-7708. ; 22:8, s. 987-992
  • Tidskriftsartikel (refereegranskat)abstract
    • Sixty-four patients with active distal ulcerative colitis participated in a multicentre, randomized, investigator-blind trial to compare the effect of budesonide enema, 2 mg/100 ml, with prednisolone disodium phosphate enema, 31.25 mg/100 ml. Budesonide is a new potent corticosteroid with a rapid first-pass elimination. The patients were treated for 4 weeks, and the efficacy of the drugs were evaluated by sigmoidoscopy, histology, and subjective symptoms after 2 and 4 weeks. After 4 weeks of treatment 16 of 31 patients (52%) receiving budesonide enema had healed endoscopically, compared with 8 of 33 (24%) (p = 0.045) receiving prednisolone enema. Budesonide was superior to prednisolone in terms of both significantly improved sigmoidoscopic and histologic scores and subjective symptoms evaluated by visual analogue scales. The patients receiving prednisolone had a significant depression of endogenous cortisol levels during the treatment period, but not the patients receiving budesonide. Budesonide enema seems to be a promising therapy for active distal ulcerative colitis and causes no adverse reactions
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Isaksson, Johan, et al. (författare)
  • Predictors of long-term survival and recurrence patterns after definitive chemoradiotherapy in stage III NSCLC – a multicenter cohort study from Mid Sweden
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • Background: Stage III NSCLC is heterogeneous but often recurs despite intensive treatment with curative intent. Clinical tools to predict the risk and pattern of recurrence and long-term survival in individual patients are largely lacking. Methods: NSCLC stage III patients (N=193) treated 2009-2018 with definitive, curatively intended chemoradiotherapy (CRT, 60Gy+) were retrospectively identified from three healthcare regions in Mid Sweden. Outcome variables included overall survival (OS), progression-free survival (PFS) and recurrence patterns.  Results:  Median follow-up of patients alive was 52 months. 1, 2 and 5-year OS was 80%, 63% and 34% with a mOS of 32 months. Pre-treatment serum inflammatory markers were associated with inferior OS, including leukocyte count > 10 (HR 1.58, 95% CI 1.08-2.31, p=0.018) and CRP > 5 (HR 1.81, 95% CI 1.16-2.83, p=0.009). CRP remained independently associated with OS in multivariable analysis, HR 1.67 (1.05-2.65, p=0.029). No other pre-treatment variable was significantly associated with OS. Progressive disease (PD) was documented in 65% of patients after a median time of 9.5 months, 96% within 3 years from CRT, and was typically either distant or locoregional (12% mixed). Distant PD developed earlier (6.3 months) than locoregional PD (11.5 months; p=0.052).  N3 disease (OR 2.7, 95% CI 1.2-6.3,; p=0.022) and presence of driver mutations (OR 4.6, 95% CI 1.5-14.0; p=0.0076) increased the risk of distant PD, while ≥2 concurrent chemotherapy courses was protective of locoregional PD (OR 0.38, 9% CI 0.1-1.0; p=0.049). Brain metastases were the first indication of PD in 22 patients (12%) and were in all cases isolated without synchronous extracranial PD. A post-CRT 18F-FDG-PET SUVmax of ≥7 was associated with a shorter time to PD (HR 0.41, 95% CI 0.21-0.79, p=0.008).   Conclusions: The study reinforces the prognostic role of systemic inflammation in stage III NSCLC and provides clinically useful indicators of relapse pattern as a basis for rational disease monitoring following CRT. 
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 12
Typ av publikation
rapport (5)
tidskriftsartikel (4)
samlingsverk (redaktörskap) (1)
annan publikation (1)
konferensbidrag (1)
Typ av innehåll
refereegranskat (8)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Rodhe, Lena (5)
Olsson, Henrik (3)
Isaksson, Johan (2)
Karlsson, Anna (2)
Micke, Patrick (2)
Svensson, Bo (2)
visa fler...
Björn, Annika (2)
Ejlertsson, Jörgen (2)
Shakeri Yekta, Sepeh ... (2)
Botling, Johan (2)
Lamberg, Kristina (2)
Sundström, Magnus (1)
Ellervik, Ulf (1)
Bergqvist, Michael (1)
Widmalm, Göran (1)
Skyllberg, Ulf (1)
Houltz, Anders (1)
Ekman, Simon (1)
Willén, Roger (1)
Olsson, Olle (1)
Koyi, Hirsh (1)
Brandén, Eva (1)
Olsson, Erik (1)
Isacsson, Ulf (1)
Lindskog, Magnus (1)
Danielsson, Åke (1)
Löfberg, Robert (1)
Manner, Sophie (1)
Nilsson, Åke (1)
Tykesson, Emil (1)
Källström, Magnus (1)
Moens, Lotte (1)
La Fleur, Linnea (1)
Johnson, Magnus T. (1)
Hansen, Tomas (1)
Holm, Olof (1)
Willén, Maja, 1983- (1)
Willén, Linda, 1979- (1)
Holgersson, Georg (1)
Vidal, Sebastien (1)
Ojong, Pascal (1)
Sandelin, Martin, 19 ... (1)
Ståhle, Jonas (1)
Broström, Erika (1)
Willén, Daniel (1)
Hellers, Göran (1)
Lyrenäs, Ebbe (1)
Olsson, Sven-Åke (1)
Persson, Tore (1)
Salde, Lars (1)
visa färre...
Lärosäte
RISE (5)
Uppsala universitet (3)
Linköpings universitet (2)
Lunds universitet (2)
Stockholms universitet (1)
Konstfack (1)
visa fler...
Karolinska Institutet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Svenska (6)
Engelska (6)
Forskningsämne (UKÄ/SCB)
Lantbruksvetenskap (5)
Medicin och hälsovetenskap (3)
Naturvetenskap (2)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy